Eyenuk
Eyenuk is a medtech company that develops an artificial intelligence screening tool for risk assessment and disease surveillance. The company's first product, the EyeArt AI Eye Screening System, is the most extensively validated AI technology for the autonomous detection of diabetic retinopathy. Eyenuk is on a mission to screen every eye in the world to ensure timely diagnosis of life-and vision-threatening diseases, including diabetic retinopathy, glaucoma, age-related macular degeneration, stroke risk, cardiovascular risk, and Alzheimer’s disease. The company was founded in 2010 and is based in Los Angeles, California.
Domain
eyenuk.com
Country
United StatesIndustry
Artificial Intelligence (AI)Employees
11-50
Last Funding
$26.0M
Founded
2009
Tech Stack (26 technologies)
Frequently Asked Questions
What technologies does Eyenuk use?+
Eyenuk uses 26 technologies including Astra, Google Analytics, Google Tag Manager.
What industry is Eyenuk in?+
Eyenuk operates in the Artificial Intelligence (AI) industry.
Where is Eyenuk based?+
Eyenuk is headquartered in United States.
Explore More
Need this data at scale?
Get ready-to-use datasets: companies, technologies, and tech adoption signals across 3M+ websites.
Browse DatasetsData last updated: June 2026